VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
WAY
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
WAYWaystar Holding Corp.
$19.98$3.8B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders

WAY logoWaystar Holding Corp.(WAY)Earnings, Financials & Key Ratios

WAY•NASDAQ
$18.96
31.1× P/E·Price updated Jun 25, 2026
SectorTechnologyIndustryIT ServicesSub-IndustryPayments Processing and Fintech Services
AboutWaystar Holding Corp. develops a cloud-based software solution for healthcare payments. Its platform offers financial clearance, patient financial care, claim and payment management, denial prevention and recovery, revenue capture, and analytics and reporting solutions. The company primarily serves healthcare industry. Waystar Holding Corp. was founded in 2017 and is based in Lehi, Utah.Show more
  • Revenue$1.1B+16.5%
  • EBITDA$407M+31.1%
  • Net Income$112M+686.1%
  • EPS (Diluted)0.61+569.2%
  • Gross Margin64.65%-2.8%
  • EBITDA Margin37%+12.5%
  • Operating Margin24.22%+84.7%
  • Net Margin10.2%+603.1%
  • ROE3.22%+532.0%

WAY Price & Volume

Waystar Holding Corp. (WAY) stock price & volume — 10-year historical chart

Loading chart...

Waystar Achieves Rapid Deleveraging and Margin Expansion

Investment Thesis • Updated 2026Q1

VerdictPositive
Growth:Accelerating
Profitability:Moderate
Financial:Healthy
Cash Flow:Robust
Primary Risk:Payer consolidation and regulatory

Key Thesis Takeaways

  • Waystar has successfully transitioned from a highly leveraged private entity to a robust public platform, evidenced by a dramatic reduction in total debt from $2.3 billion in 2024Q1 to $30.6 million in 2026Q1.
  • The company is capturing significant market share in the healthcare revenue cycle management sector, with revenue growth accelerating to 22.4% in 2026Q1.
  • While the firm's reliance on inorganic growth through acquisitions—highlighted by a $629.5 million outlay in 2025Q4—and a heavy goodwill-to-asset ratio of approximately 69% warrants caution, the underlying operational leverage and improving free cash flow margins suggest a sustainable path toward long-term profitability.

Verdict Logic

the company's rapid deleveraging and strong 25.6% operating margin in 2026Q1 suggest a compelling fundamental turnaround that justifies its current valuation.

WAY Growth Metrics

Waystar Holding Corp. (WAY) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years15.97%
TTM18.61%

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM383.6%

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM412.62%

Return on Capital

10 Years2.88%
5 Years2.88%
3 Years3.72%
Last Year5.24%

WAY Recent Earnings

Waystar Holding Corp. (WAY) EPS & revenue vs analyst estimates — last 4 quarters

Full history →
●Beat EPS 6/12 qtrs (75%)●Beat Revenue 6/12 qtrs (75%)
Q2 2026Latest
Apr 29, 2026
Metric
Actual
Est
EPS
$0.42+7.7%
$0.39
Rev
$314M+0.7%
$312M
Q1 2026
Feb 17, 2026
Metric
Actual
Est
EPS
$0.36-7.7%
$0.39
Rev
$304M+3.0%
$295M
Q4 2025
Oct 29, 2025
Metric
Actual
Est
EPS
$0.37+8.8%
$0.34
Rev
$269M-8.8%
$295M
Q3 2025
Jul 30, 2025
Metric
Actual
Est
EPS
$0.36+9.1%
$0.33
Rev
$271M+5.7%
$256M
QuarterDateEPS (Act vs Est)Revenue (Act vs Est)
Q2 2026LatestApr 29, 2026
$0.42vs $0.39+7.7%
$314Mvs $312M+0.7%
Q1 2026Feb 17, 2026
$0.36vs $0.39-7.7%
$304Mvs $295M+3.0%
Q4 2025Oct 29, 2025
$0.37vs $0.34+8.8%
$269Mvs $295M-8.8%
Q3 2025Jul 30, 2025
$0.36vs $0.33+9.1%
$271Mvs $256M+5.7%
Based on last 12 quarters of dataView full earnings history →

Latest WAY News

Recent stock market news and headlines for Waystar Holding Corp. (WAY)

Seeking Alpha·Jun 18, 2026
Waystar: Silently Taking Over Healthcare Billing

Waystar Holding Corp. is rated buy, with an 85% upside to a $37 price target, as current share price reflects temporary private equity (PE) selling pressure, not business fundamentals. Waystar's revenue grew 22% YoY, profit margins remain above 40%, and a $200M buyback offsets PE overhang; 23 of 24 analysts rate it Buy/Strong Buy. The Iodine acquisition and AI-powered AltitudeAI suite expand WAY's end-to-end billing solutions, driving new client wins and high retention in a $100B+ addressable market.

Peers Comparison

Key metrics vs top competitors for Waystar Holding Corp. (WAY)

Full Screener →
CompanyPriceMarket CapP/E RatioRev Growth (1Y)Net MarginROEDiv Yield
WAY logoWAYWaystar Holding Corp.Current
$18.96$3.64B31.0816.5%10.2%3.22%—
NVCR logoNVCRNovoCure Limited
$15.05$1.71B-12.348.28%-25.66%-50.82%—
COLL logoCOLLCollegium Pharmaceutical, Inc.
$34.84$1.13B20.1423.62%9.41%26.74%—
MTEX logoMTEXMannatech, Incorporated
$5.03$9.71M-0.63-8.34%-11.97%-2383.34%—
VEEV logoVEEVVeeva Systems Inc.
$158.08$25.68B29.0616.34%28.37%13.36%—
HIMS logoHIMSHims & Hers Health, Inc.
$32.71$7.18B64.1459%-0.56%-2.48%—

Compare WAY vs Peers

Waystar Holding Corp. (WAY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs NVCR

Most directly comparable listed peer for WAY.

Scale Benchmark

vs UNH

Larger-name benchmark to compare WAY against a more recognizable public peer.

Peer Set

Compare Top 5

vs NVCR, COLL, MTEX, VEEV

WAY SEC Filings & Documents

Waystar Holding Corp. (WAY) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

6
Material company update

Apr 29, 2026·SEC

Material company update

Feb 17, 2026·SEC

Material company update

Feb 6, 2026·SEC

10-K Annual Reports

2
FY 2026

Feb 17, 2026·SEC

FY 2025

Feb 18, 2025·SEC

10-Q Quarterly Reports

6
FY 2026

Apr 29, 2026·SEC

FY 2025

Oct 29, 2025·SEC

FY 2025

Jul 30, 2025·SEC

Get notified when WAY posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

WAY Frequently Asked Questions

Waystar Holding Corp. (WAY) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials
What is Waystar Holding Corp.'s revenue?

Waystar Holding Corp. (WAY) reported $1.16B in revenue for fiscal year 2025. This represents a 100% increase from $578.6M in 2021.

How fast is Waystar Holding Corp. growing?

Waystar Holding Corp. (WAY) grew revenue by 16.5% over the past year. This is strong growth.

Is WAY profitable?

Yes, Waystar Holding Corp. (WAY) is profitable, generating $126.1M in net income for fiscal year 2025 (10.2% net margin).

Dividend & Returns
What is WAY's return on equity?

Waystar Holding Corp. (WAY) has a return on equity (ROE) of 3.2%. This is below average, suggesting room for improvement.

What is Waystar Holding Corp.'s free cash flow?

Waystar Holding Corp. (WAY) generated $294.0M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.

What if you invested $1,000 in WAY back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →